Phase III multicenter trial of doxorubicin plus cyclophosphamide followed by paclitaxel compared with doxorubicin plus paclitaxel followed by weekly paclitaxel as adjuvant therapy for women with high-risk breast cancer.
暂无分享,去创建一个
J. Hainsworth | N. Robert | N. Senzer | H. Burris | F. Holmes | J. Pippen | J. Blum | F. Greco | S. Vukelja | L. Asmar | M. Modiano | H. Burris | S. Sedlacek | J. Sandbach | Stephen N. Jones | D. Loesch | K. McIntyre | K. Boehm | F. Zhan | D. Lindquist